missing translation for 'onlineSavingsMsg'
Learn More

Phospho-MEK1 (Ser298) Mouse Monoclonal Antibody, Proteintech

Mouse Monoclonal Antibody

119.78 € - 321.08 €

Spezifikation

Antigen MEK1 (Ser298)
Klon 3F10G10
Konzentration 1000 μg/mL
Anwendungen Western Blot, ELISA
Konjugat Unconjugated
Mehr Spezifikationen ansehen

Products 2
Product Code Brand Menge Price Quantity & Availability  
Product Code Brand Menge Price Quantity & Availability  
30236910
View Documents
Proteintech
68047-1-IG-100UL
100 μL
321.08 €
100 Mikroliter
View alternative products
Save Up to 
»
Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!
30235170
View Documents
Proteintech
68047-1-IG-20UL
20 μL
119.78 €
20 Mikroliter
View alternative products
Save Up to 
»
Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!
Description

Description

The Phospho-MEK1 (Ser298) antibody from Proteintech is a mouse monoclonal antibody generated with peptide of human Phospho-MEK1 (Ser298). This antibody recognizes human antigen. The Phospho-MEK1 (Ser298) antibody has been validated for the following applications: WB, ELISA analysis.
Specifications

Specifications

MEK1 (Ser298)
1000 μg/mL
Unconjugated
Mouse
5604
Peptide
Primary
Store at -20°C.
3F10G10
Western Blot, ELISA
Liquid
Human
MAPKK1; MEK1; MKK1; PRKMK1
IgG1
Protein G purification
Monoclonal Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.